US Stock MarketDetailed Quotes

SBFM Sunshine Biopharma

Watchlist
  • 2.8600
  • +0.1300+4.76%
Close Nov 29 13:00 ET
  • 2.9800
  • +0.1200+4.20%
Post 17:01 ET
5.72MMarket Cap-22P/E (TTM)

Sunshine Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sunshine Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 15.500M--
--2024/Q38.435M / 11.800M--
--2024/Q29.303M / 9.000M--
--2024/Q17.541M / 7.000M--
--2023/Q47.680M / 6.100M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 15.500M--
--2024/Q38.435M / 11.800M--
--2024/Q29.303M / 9.000M--
--2024/Q17.541M / 7.000M--
--2023/Q47.680M / 6.100M--

Unlock Free Earnings Estimates

Sunshine Biopharma Earnings Reports

  • 8-K: SUNSHINE BIOPHARMA REPORTS 2024 THIRD QUARTER RESULTS: YEAR-TO-DATE REVENUES UP 54%

    Nov 7 16:48 ET

  • 10-Q: Q3 2024 Earnings Report

    Nov 5 16:06 ET

  • 10-Q/A: Quarterly report (Amendment)

    Aug 20 16:09 ET

  • 8-K: SUNSHINE BIOPHARMA REPORTS 2024 SECOND QUARTER RESULTS: SECOND QTR REVENUES UP 67%, YTD REVENUES UP 61%

    Aug 19 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data